Tmprss2 Erg - Histology

Relevant Publications

Re: Use of TP4303 to identify prostate cancer cells in voided urine samples.

Issue Release: 2024

Prognostic utility of biopsy-based and status on biochemical progression and overall survival after SBRT for localized prostate cancer.

Issue Release: 2024

Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles.

Issue Release: 2024

Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.

Issue Release: 2024

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer.

Issue Release: 2024

The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials.

Issue Release: 2024

From microscopes to molecules: The evolution of prostate cancer diagnostics.

Issue Release: 2024

Effect of nonsteroidal anti-inflammatory drugs (aspirin and naproxen) on inflammation-associated proteomic profiles in mouse plasma and prostate during TMPRSS2-ERG (fusion)-driven prostate carcinogenesis.

Issue Release: 2024

Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.

Issue Release: 2024

Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.

Issue Release: 2024

Amplification of different satellite-DNAs in prostate cancer.

Issue Release: 2024

Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [Ga]Ga-PSMA-11 PET scans of primary prostate cancer.

Issue Release: 2024

A cross-sectional study of ERG expression and the relationship with clinicopathological features of Prostate cancer in Southwestern Uganda.

Issue Release: 2024

Histopathologic and Molecular Characterization of IDH-Mutant Prostatic Adenocarcinoma.

Issue Release: 2024

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

Issue Release: 2024

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition.

Issue Release: 2024

Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images.

Issue Release: 2024

TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer.

Issue Release: 2024

Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature.

Issue Release: 2024

PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer.

Issue Release: 2024

What are the Challenges of Implementing CI in Histology?

What is Cancer Staging?

How to Use Histology Databases Effectively?

Why are Biorepositories Important in Histology?

What is the Role of Myelin in Neural Signals?

Are There Histological Markers for Radiotherapy Response?

What Are the Histological Changes During Pregnancy?

What Are Some Common Stains Used in Histology That Rely on Adsorption?

Why Are Proteins Important in Histology?

What is the Role of Automation in Tissue Staining?

Tmprss2 Erg - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics